Bacterial sepsis is a major cause of fatality worldwide and the increasing multidrug-resistant bacteria is a major concern for public health and modern health systems (Breijyeh et al., Molecules 25(6):1340, 2020). Sepsis is a multi-step process that involves an uncontrolled inflammatory response by the host cells that may result in multi organ failure and death. Both gram-negative and gram-positive bacteria play a major role in causing sepsis. Surviving Sepsis Campaign recommends urgent stabilization of the patient, volume resuscitation, vasopressors and/or inotropic therapy to restore perfusion, and the administration of broad spectrum, empirical antibiotic therapy in the setting of an intensive care unit (ICU) (Evans et al., Intensive Care Med 47(11):1181-1247, 2021). However, antibiotic-induced release of bacterial cell wall components can have immediate adverse effects for the patient (Schulze et al., Res Exp Med 200: 169-174, 2001; Lepper et al. Intensive Care Med 28: 824-833, 2002). Particularly, some classes of beta-lactam antibiotics lead to markedly increased levels of free endotoxins while treatment with carbapenems and aminoglycosides produces relatively low amounts of endotoxins. Polymyxins are effective (Trimble et al., Cold Spring Harb Perspect Med 6(10):a025288, 2016; Lepper et al., Intensive Care Med 28(7):824-33, 2002) and able to bind to endotoxin (LPS) and phospholipids in the outer cell membrane of Gram-negative bacteria. However, systemic administration of polymyxin B (PMX-B) in humans is restricted because of its nephrotoxicity and neurotoxicity. Nowadays, new techniques based on the extracorporeal circulation of blood have been developed. In this chapter, we will review the effect of extracorporeal removal of endotoxin. Particularly, PMX-B is a strong ligand for the extracorporeal selective adsorption of circulating endotoxin in blood (Tani et al., Adv Exp Med Biol 1145:321-341, 2019), largely described in literature, and for this reason it will be depicted in detail in the present chapter.

Extracorporeal Removal of Endotoxin / De Rosa, S., Lorenzin, A., Villa, G., Ronco, C.. - (2023), pp. 127-133. [10.1007/978-3-031-18591-5_14]

Extracorporeal Removal of Endotoxin

De Rosa Silvia;
2023-01-01

Abstract

Bacterial sepsis is a major cause of fatality worldwide and the increasing multidrug-resistant bacteria is a major concern for public health and modern health systems (Breijyeh et al., Molecules 25(6):1340, 2020). Sepsis is a multi-step process that involves an uncontrolled inflammatory response by the host cells that may result in multi organ failure and death. Both gram-negative and gram-positive bacteria play a major role in causing sepsis. Surviving Sepsis Campaign recommends urgent stabilization of the patient, volume resuscitation, vasopressors and/or inotropic therapy to restore perfusion, and the administration of broad spectrum, empirical antibiotic therapy in the setting of an intensive care unit (ICU) (Evans et al., Intensive Care Med 47(11):1181-1247, 2021). However, antibiotic-induced release of bacterial cell wall components can have immediate adverse effects for the patient (Schulze et al., Res Exp Med 200: 169-174, 2001; Lepper et al. Intensive Care Med 28: 824-833, 2002). Particularly, some classes of beta-lactam antibiotics lead to markedly increased levels of free endotoxins while treatment with carbapenems and aminoglycosides produces relatively low amounts of endotoxins. Polymyxins are effective (Trimble et al., Cold Spring Harb Perspect Med 6(10):a025288, 2016; Lepper et al., Intensive Care Med 28(7):824-33, 2002) and able to bind to endotoxin (LPS) and phospholipids in the outer cell membrane of Gram-negative bacteria. However, systemic administration of polymyxin B (PMX-B) in humans is restricted because of its nephrotoxicity and neurotoxicity. Nowadays, new techniques based on the extracorporeal circulation of blood have been developed. In this chapter, we will review the effect of extracorporeal removal of endotoxin. Particularly, PMX-B is a strong ligand for the extracorporeal selective adsorption of circulating endotoxin in blood (Tani et al., Adv Exp Med Biol 1145:321-341, 2019), largely described in literature, and for this reason it will be depicted in detail in the present chapter.
2023
Alessandro Perrella; Novella Carannante; Nicolina Capoluongo; Annamaria Mascolo; Annalisa Capuano; Marta Pillitteri; Etrusca Brogi; Chiara Piagnani; Francesco Forfori; Salvatore Lucio Cutuli; Gabriele Pintaudi; Melania Cesarano; Gennaro De Pascale; Ahsina Jahan Lopa; Saurabh Debnath; Erika Paola Plata-Menchaca; Ricard Ferrer; Massimo de Cal; Grazia Maria Virzì; Veronica Gennenzi; Joel Vargas; Gennaro De Pascale; Marzia Savi; Andrea Montisci; Massimiliano Greco; Annalisa Boscolo; Nicolò Sella; Tommaso Pettenuzzo; Paolo Navalesi; Giulia Cocci; Raffaella d’Errico; Gianluca Villa, Stefano Romagnoli; Silvia Pierantozzi; Tiziana Principi; Salomone Di Saverio; Franco Turani; Gabriele Barettin; Silvia Busatti; Fabrizio Vannicola; Denise Battaglini; Lucia Cattin; Silvia De Rosa; Gianluca Paternoster; Anna Lorenzin, Gianluca Villa; Claudio Ronco
Endotoxin Induced-Shock: a Multidisciplinary Approach in Critical Care
Cham
Springer Cham
978-3-031-18590-8
De Rosa, Silvia; Lorenzin, Anna; Villa, Gianluca; Ronco, Claudio
Extracorporeal Removal of Endotoxin / De Rosa, S., Lorenzin, A., Villa, G., Ronco, C.. - (2023), pp. 127-133. [10.1007/978-3-031-18591-5_14]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11572/489096
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex 1
social impact